Renda Kangjian
Latest round
- Angel
Last raised
- Sep 2023
Total raised
- Undisclosed
Investors
- 1
About Renda Kangjian
Founded in 2022 and based in Xianyang, China, Renda Kangjian Renda operates as a biopharmaceutical company that focuses on the research and development of anti-Alzheimer drugs and related products. It was founded by the team of Wenxia Han from Xi’an Medical University. The company acquired more than 10 invention patents in the field of Huperzine A API. The company was approved for more than 700 square meters of factory land in early 2024. Renda Kangjian mainly engages in the research and development of anti-Alzheimer drugs. Its main product is Huperzine A APIs. Its synthesized Huperzine A are synthesized based on self-developed biosynthesis technologies, which also preserve the composition and activity. Products can be used in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company generates revenue by providing anti-Alzheimer drugs and related products. The company will use the strategic investment for technology development and product promotion.
Who invested in Renda Kangjian
1 investor across 1 round
See all investors in Renda Kangjian
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Sep 1, 2023
Amount
Undisclosed
Investors
Questions about Renda Kangjian
Who invested in Renda Kangjian?
Renda Kangjian has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Renda Kangjian raised?
Renda Kangjian has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Renda Kangjian last raise money?
Renda Kangjian's most recent round on record is a Angel, in Sep 2023.
What does Renda Kangjian do?
Founded in 2022 and based in Xianyang, China, Renda Kangjian Renda operates as a biopharmaceutical company that focuses on the research and development of anti-Alzheimer drugs and related products.
Where is Renda Kangjian headquartered?
Renda Kangjian is headquartered in Xianyang, China.
Which VCs invest in companies like Renda Kangjian?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Renda Kangjian's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Renda Kangjian? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.